Dr. Aparna Dhar is a Mayo Clinic College of Medicine and University of Glasgow trained Medical Geneticist and Genetic Counsellor. She has over fifteen years of experience in academia, hereditary cancers and personalized genomic testing for guiding patient treatment and management. Over 10,000 families have benefitted from her Cancer Genetics clinic. Through the Genetics clinic a combination of genetic education and psychosocial support is implemented to empower patients to make informed decisions regarding their health. She has also gained experience as a Research fellow, Medical Geneticist & Genetic counsellor at Mayo Clinic, Broad Institute of MIT and Harvard and National Health Services (NHS) Scotland.

Dr. Chehal served as head of Hematology Oncology division at Sheikh Shakhbout Medical City from December 2019 until August 2020. Dr. Chehal main interests are Lung, Breast, Gyne, GI and GU malignancies.

Dr. Aydah is a Medical Oncologist and quality officer in Oncology at Tawam hospital, graduated from the MD Anderson Hematology and Medical Oncology fellowship in 2019. Main interest in breast cancer. Published several peer review research articles and multiple book chapters in breast cancer. She is American board certified in Internal Medicine, Hematology and Oncology.

Dr. Bhawna Sirohi is currently a consultant medical oncologist in GI & breast cancers and Director of Medical Oncology at BALCO Medical Centre,Nava Raipur, India. She is an honorary consultant with Queen Mary’s University, London. She was previously working at The Barts Health NHS Trust, London. She started her oncology training in India in 1994 at the Tata Memorial Centre, Mumbai and completed at Royal Marsden NHS Foundation Trust, UK. She has been working as consultant medical oncologist since 2008, in breast and GI cancers and acute oncology, both in India and UK. She has published more than 100 papers in national and international journals and lectured worldwide. She has edited three books on Cancer – Cancer- Questions Answered, Chemotherapy in GI cancers & Modern GI Oncology. She is the immediate past editor-in-chief of Indian Journal of Medical and Paediatric Oncology. She is currently the President of the Oncology section of the Royal Society of Medicine.

“Consultant Medical Oncology, DAHC since 2009 Ass prof Clinical Oncology Tanya University Egypt PhD clinical Oncology 2008 Master Clinical Oncology 2001 Member of ASCO, ESMO more than 20 Publications “

Dr. Diaeddine Trad is a Consultant of Medical Oncology, at Tawam Hospital, in Al Ain, UAE. He is a member of the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). He is an investigator in several ongoing clinical trials. Dr. Trad is certified as a specialist in internal medicine, hematology and oncology by the Lebanese Ministry of Health. His research interests include; Lung cancer, GI malignancies, and breast cancer. Dr. Trad was a speaker in many international conferences and forums.

Dr. Dima Abdul Jabbar, MD, is a staff physician in the Oncology Institute at Cleveland Clinic Abu Dhabi. Prior to joining Cleveland Clinic Abu Dhabi, Dr. Dima served as Assistant Professor of Medical Oncology at the University of South Florida, H. Lee Moffitt Cancer Center and Research Institute, Florida, US. She has also worked as a Consultant Medical Oncologist at several reputable hospitals in Florida and the UAE. Dr. Dima has extensive experience with different types of chemotherapy and immunotherapy and has managed different kinds of cancers including breast cancer, melanomas, and colorectal neoplasms.

Dr. Emad Dawoud is a Consultant Medical Oncologist in Oncology department at Tawam hospital UAE, and Assistant professor of clinical oncology in Al Azhar University Cairo, Egypt. Dr. Dawoud has been principal investigator and co- investigator for more than 50 clinical trials and abstract published per reviewed journals and he is a member of various associations such as ASCO, ESMO, ESTRO.

Asst Prof Dr. Faraz Khan is a Consultant Hematologist and Medical Oncologist with over 15 years experience in treating cancer and various blood diseases. He completed his Internal Medicine, Hematology and Medical oncology training from the University of Connecticut, CT, USA and is triple board certified in Internal medicine, Hematology and Medical Oncology. He worked as a consultant Hematologist/Medical Oncologist at PEI Cancer Treatment Center, PE, Canada and directed the provincial hemophilia and bleeding disorder clinic.

Dr. Hassan Shahryar is a consultant in medical oncology and hematology at the Sheikh Shakbout Medical City (SSMC) in partnership with Mayo Clinic and an adjunct clinical Associate Professor of Medicine at the Khalifa University in Abu Dhabi, UAE. He is Diplomate American Board of Internal Medicine, Geriatrics, Medical Oncology and Haematology. Dr. Shahryar practices general oncology in a large tertiary care public health system with a special interest in breast tumors. Dr. Shahryar is well published in peer reviewed international journals and is an invited speaker at the national and regional cancer conferences. He is a participant of the ESMO Leaders Generation Programme Asia 2022 and an active member of the ESMO Leadership Development Committee.

Dr. Shiu is a Consultant in the Gastrointestinal Oncology Unit at University College London Hospital NHS Foundation Trust and Honorary Associate Professor at the UCL Cancer Institute. His research interests include immunotherapy for GI malignancies and Cancer of Unknown Primary, as well as the development of novel cancer clinical trial designs. He is the Principal Investigator of the UCL/UCLH Gastrointestinal Cancer Translational Research Biobank and member of ASCO, ESMO and the Chair of the Association of Cancer Physicians New Consultant Group.

Dr. Das is a senior specialist oncologist in Dubai academic and health corporation (formerly DHA) since more than a decade. He has done his internal medicine fellowship in 2008 and medical Oncology fellowship in 2011. He continued his clinical and academic excellence and achieved membership of American college of physicians and royal college of physicians and surgeons Glasgow, UK mad succeed to get specialty certification in medical oncology from Royal college of physician UK. He has worked on different positions in Pakistan, Qatar and in UAE. He has been participating as faculty member in EIOC (formerly UAE-CC) since 09 consecutive years.

She is the Head and Senior Consultant in Medical Oncology and Associate Director of Research at the National University Cancer Institute, Singapore, and Senior Principal Investigator at the Cancer Science Institute, Singapore. She is ex-Chairperson of the Chapter of Medical Oncologists, Academy of Medicine, Singapore, and has been a member of the Ministry of Health Specialist Accreditation Board for Medical Oncology since 2009. She has been Chair of the National Healthcare Group Domain-Specific Ethics Review Board B since 2008. She is also a member of the Singapore Ministry of Health Drug Advisory Committee for Oncology drugs. She specialises in breast cancer and directs the Cancer Genetics program at the National University Cancer Institute, Singapore. Her research focus is on breast cancer, pharmacogenetics and cancer genetics, and she has been the Principal Investigator of more than 40 industry-sponsored and investigator-initiated breast cancer clinical trials. She directs the Haematology-Oncology Research Group, a cancer clinical trials unit that conducts 100-120 phase I-III therapeutics clinical trials in solid tumours and haematological malignancies at the National University Cancer Institute.

Dr Prabhat is Additional Professor, in the Department of Medical Oncology, at All India Institute of Medical Sciences, New Delhi. His Major scientific fields of interest are Lung Cancer treatment, Molecular profiling and targeted therapies in NSCLC, Cancer immunology and Metronomic therapies and drug repositioning.

 Shaheenah Dawood is a consultant medical oncologist and professor in clinical oncology in the United Arab Emirates. She currently leads the oncology clinical trials program at Mediclinic City Hospital Dubai. She also serves as president of the Excellence in Oncology Care summit that is held annually in Dubai and is co-president of the Asia-Pacific Breast Cancer Summit (APBCS) and Asia-Pacific Gastroenterology Cancer Summit (APGCS). She has also recently launched the International BRCA Forum and Young Women’s Forum.

Dr. Sonia Otsmane is an experienced Medical Oncology-Haematology Consultant since 2004. Graduated from the Central faculty of Medecine Algiers in 1994. MD degree. Oncology-hematology board : Pierre and Marie curie institute in 2004. ESMO member. Member of ASCO. Member of Emirates oncology and hematology society. Member of Oncology society and Algerian order of physicians. Main interest: breast cancer, sarcomas, GI and GU malignancies and lymphomas. Has an interest and implicated in several clinical research. Publications and research ongoing on Hematology malignancies (Multiple myeloma /Lymphoma), Solid tumors mainly Breast cancer Head and neck tumors and Immunotherapy.

Stephen Johnston is a Professor of Breast Cancer Medicine and Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London. He is currently a Clinical Director of the Breast, Lung and AOS Clinical Business Unit at The Royal Marsden. He has published over 250 breast cancer related articles in peer-reviewed journals, and is a regular invited lecturer at national and international meetings.